Fulvestrant/palbociclib
MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways
Fulvestrant enables better outcomes
Fulvestrant
[Fulvestrant].
Carboplatin/fulvestrant